Mydecine Innovations Group Inc. (MYCOF)

0.0128 0.0000 (0.00%) As of 02:40PM EDT. Market open.

Mydecine Innovations Group Inc.

789 West Pender Street
Suite 810
Vancouver, BC V6C 1H2
Canada
720-277-9879
https://www.mydecine.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 3

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. David Joshua Bartch	Co-Founder, CEO, President & Chairman of the Board	324.23k	N/A	1988
Mr. Robert Roscow M.A.	Co-Founder, Chief Scientific Officer & Director	332.1k	N/A	N/A
Mr. Damon Michaels	Co-Founder & COO	332.1k	N/A	N/A
Mr. John Charles Ross CA, CPA, M.B.A.	CFO & Corporate Secretary	6.71k	N/A	1958
Mr. Sanford M. Stein	Chief Compliance Officer & General Counsel	231.48k	N/A	N/A
Dr. Rakesh Jetly FRCPC, M.D.	Chief Medical Officer	197.81k	N/A	N/A
Morgan Kervitsky	Director of Marketing	N/A	N/A	N/A
Mr. Michel Rudolphie	President of the European Operations	N/A	N/A	N/A
Mr. William Cook	Interim CEO & Technical Director of Mindleap Health Inc.	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Mydecine Innovations Group Inc., a biotechnology company, engages in the development and commercialization of psilocybin products for treating mental health problems. The company primarily focuses on treating smoking cessation. Its lead product drug candidates include MYCO-001, MYCO-002, MYCO003, and MYCO-004. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.

Corporate Governance

Mydecine Innovations Group Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.